Granisetron Fresenius i.v. 1mg/1ml

Granisetron Fresenius i.v. 1mg/1ml is a medicine authorised by Swissmedic under authorisation number 65050. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 September 2014 and the authorisation is valid without a time limit. ATC code A04AA02 places the medicine in the group Antiemetics and antinauseants.

  • Dispensing category B
  • Authorisation number 65050
  • ATC A04AA02
  • Synthetic medicines
Authorisation data
Authorisation number65050
NameGranisetron Fresenius i.v. 1mg/1ml
Full nameGranisetron Fresenius i.v. 1mg/1ml, Infusionskonzentrat
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA04AA02
First authorisation26 September 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Granisetron Fresenius i.v. 1mg/1ml, InfusionskonzentratB26 September 2014
2Granisetron Fresenius i.v. 3mg/3ml, InfusionskonzentratB26 September 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15Ampulle(n)A04AA0201.09.0.B
35Ampulle(n)A04AA0201.09.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Granisetron Fresenius i.v. 1mg/1ml authorised in Switzerland?

Yes. Granisetron Fresenius i.v. 1mg/1ml is authorised by Swissmedic under authorisation number 65050, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Granisetron Fresenius i.v. 1mg/1ml have?

Granisetron Fresenius i.v. 1mg/1ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Granisetron Fresenius i.v. 1mg/1ml?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com